Cardiac Imaging for Assessment of Left Ventricular Thrombus

Cardiac Imaging for Assessment of Left Ventricular Thrombus

Chinitz Jason S , Kim Raymond J , Mendoza Dorinna D, Weinsaft Jonathan W

US Cardiology, 2009;6(2):27-33

download article View ebook

| More
dots

Abstract
Accurate detection of left ventricular (LV) thrombus is important, as thrombus provides a substrate for thromboembolic events and a rationale for anticoagulation. Non-contrast echocardiography (echo) detects LV thrombus based on anatomical appearance. This approach can be straightforward when thrombus is large in size and protuberant in shape, but challenging when thrombus is small or mural. While thrombi can vary in size and shape, it can be intrinsically defined based on avascular tissue composition. Contrast-enhanced imaging can be used to facilitate anatomical and tissue characterization approaches for thrombus detection. Contrast echo, which identifies thrombus based on anatomical appearance, provides improved thrombus detection versus non-contrast echo. Both perfusion echo and delayed-enhancement magnetic resonance imaging (MRI) assess thrombus based on tissue characteristics and improve diagnostic performance compared with MRI or echo approaches that assess thrombus based on anatomical appearance. Tissue characterization is particularly advantageous for detection of small or mural thrombus. This article reviews the role of cardiac imaging for LV thrombus, with a focus on recent advances in thrombus detection as provided by contrast-enhanced imaging.
Keywords
Left ventricular thrombus, echocardiography, magnetic resonance imaging, contrast

Disclosure: Jonathan W Weinsaft, MD, is the recipient of a research grant from Lantheus Medical Imaging (echo contrast manufacturer). The remaining authors have no conflicts of interest to declare.
Received: August 27, 2009 Accepted: September 22, 2009
Correspondence: Jonathan W Weinsaft, MD, Assistant Professor of Medicine, Greenberg Division of Cardiology, Weill Medical College of Cornell University, 525 East 68th Street, Starr-4, New York, NY 10021. E: jww2001@med.cornell.edu

Accurate detection of left ventricular (LV) thrombus affects clinical outcomes and therapeutic management, as thrombus provides a substrate for thromboembolic events and a rationale for anticoagulation. Relative risk (RR) for thrombus development is highest among subjects with systolic heart failure or myocardial infarction (MI), reflecting a link between impaired LV blood stasis, pro-coagulant mediators, and thrombosis. As the prevalence of heart failure and coronary artery disease (CAD) continues to increase, the clinical importance of accurate diagnostic imaging for thrombus is heightened. Non-contrast echocardiography (echo) is widely used to detect thrombus based on its anatomical appearance. This imaging approach is effective when thrombus is large in size or protuberant (intracavitary) in shape, but can be challenging when thrombus is small or flat (mural). Recent studies have reported that up to two-thirds of LV thrombi can be missed by routine non-contrast echo, with mural or small thrombi least likely to be detected.1–4

These limitations have spurred the use of contrast-enhanced imaging for improved thrombus detection. Two major imaging approaches have been used for this purpose: contrast can be used to opacify the LV cavity and thereby facilitate detection of thrombus based on anatomical appearance; alternatively, contrast can be used to identify thrombus based on tissue characteristics. Each of these contrastenhanced imaging approaches has been shown to provide incremental value over non-contrast echo for detection of LV thrombus. This article reviews the role of cardiac imaging for LV thrombus, with a focus on recent improvements in thrombus detection as provided by contrast-enhanced imaging.

Definition of Left Ventricular Thrombus Anatomical Criteria
Thrombus has traditionally been identified based on its anatomical appearance (see Figure 1A). Echo studies have generally defined thrombus as a mass within the LV cavity with margins distinct from ventricular endocardium and distinguishable from papillary muscles, chordae, trabeculations, or technical artifacts.5,6 Additional features, such as pattern of mobility,7 size,8 and associated ventricular wall motion abnormalities,9–13

To register to view full article click here

Keywords:
Left ventricular thrombus, thrombolytic therapy, transmural myocardial infarction, myocardial infarction complications, echocardiography, magnetic resonance imaging, two dimensional echocardiography, contrast

References:
  • Mollet NR, Dymarkowski S, Volders W, et al., Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease, Circulation, 2002;106:2873–6.
  • Srichai MB, Junor C, Rodriguez LL, et al., Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation, Am Heart J, 2006;152:75–84.
  • Weinsaft JW, Kim HW, Shah DJ, et al., Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction, J Am Coll Cardiol, 2008;52:148–57.
  • Weinsaft JW, Kim RJ, Ross M, et al., Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus, J Am Coll Cardiol Img, 2009;2:969–79.
  • Asinger RW, Mikell FL, Elsperger J, Hodges M, Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography, N Engl J Med, 1981;305:297–302.
  • Domenicucci S, Chiarella F, Bellotti P, et al., Long-term prospective assessment of left ventricular thrombus in anterior wall acute myocardial infarction and implications for a rational approach to embolic risk, Am J Cardiol, 1999;83:519–24.
  • Motro M, Barbash GI, Hod H, et al., Incidence of left ventricular thrombi formation after thrombolytic therapy with recombinant tissue plasminogen activator, heparin, and aspirin in patients with acute myocardial infarction, Am Heart J, 1991;122:23–6.
  • Blondheim DS, Jacobs LE, Kotler MN, et al., Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus, Am Heart J, 1991;122:763–71.
  • Neskovic AN, Marinkovic J, Bojic M, Popovic AD, Predictors of left ventricular thrombus formation and disappearance after anterior wall myocardial infarction, Eur Heart J, 1998;19:908–16.
  • Porter A, Kandalker H, Iakobishvili Z, et al., Left ventricular mural thrombus after anterior ST-segment-elevation acute myocardial infarction in the era of aggressive reperfusion therapy—still a frequent complication, Coron Artery Dis, 2005;16:275–9.
  • Chiarella F, Santoro E, Domenicucci S, et al., Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction inthe GISSI-3 study, Am J Cardiol, 1998;81:822–7. li> Nihoyannopoulos P, Smith GC, Maseri A, Foale RA, The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity, J Am Coll Cardiol, 1989;14:903–11.
  • Stratton JR, Lighty GW Jr, Pearlman AS, Ritchie JL, Detection f left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity, and causes of uncertainty, Circulation, 1982;66:156–66.
  • Johannessen KA, Nordrehaug JE, von der Lippe G, Vollset SE, Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction, Br Heart J, 1988;60:104–10.
  • Kirkpatrick JN, Wong T, Bednarz JE, et al., Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging, J Am Coll Cardiol, 2004;43:1412–19.
  • Mansencal N, Revault-d’Allonnes L, Pelage JP, et al., Usefulness of contrast echocardiography for assessment of intracardiac masses, Arch Cardiovasc Dis, 2009;102:177–83.
  • Krauser DG, Cham MD, Tortolani AJ, et al., Clinical utility of delayed-contrast computed tomography for tissue characterization of cardiac thrombus, J Cardiovasc Comput Tomogr, 2007;1:114–18.
  • Mansencal N, Nasr IA, Pilliere R, et al., Usefulness of contrast echocardiography for assessment of left ventricular hrombus after acute myocardial infarction, Am J Cardiol, 2007;99:1667–70.
  • Thanigaraj S, Schechtman KB, Perez JE, Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement, J Am Soc Echocardiogr, 1999;12:1022–6.
  • Kurt M, Shaikh KA, Peterson L, et al., Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort, J Am Coll Cardiol, 2009;53:802–10.
  • Mulvagh SL, Rakowski H, Vannan MA, et al., American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography, J Am Soc Echocardiogr, 2008;21:1179–1201, quiz 1281.
  • Revised Healthcare Professional Letter (May 6, 2008) and Full Prescribing Information for Definity. Available at: www.definityimaging.com/prescribing_info.html (accessed August 17, 2009).
  • Kusnetzky LL, Khalid A, Khumri TM, et al., Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies, J Am Coll Cardiol, 2008;51:1704–6.
  • Dolan MS, Gala SS, Dodla S, et al., Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience, J Am Coll Cardiol, 2009;53:32–8.
  • Herzog CA, Incidence of adverse events associated with use of perflutren contrast agents for echocardiography, JAMA, 2008;299:2023–5.
  • Wei K, Mulvagh SL, Carson L, et al., The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses, J Am Soc Echocardiogr, 2008;21:1202–6.
  • Nucifora G, Marsan NA, Siebelink HM, et al., Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarction, Eur J Echocardiogr, 2008;9:816–18.
  • Aggeli C, Giannopoulos G, Roussakis G, et al., Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection ofischaemia in 5250 studies, Heart, 2008;94:1571–7.
  • Katayama H, Yamaguchi K, Kozuka T, et al., Adversereactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media, Radiology, 1990;175:621–8.
  • Prince MR, Zhang H, Morris M, et al., Incidence of nephrogenic systemic fibrosis at two large medical centers, Radiology, 2008;248:807–16.
  • Cheitlin MD, Armstrong WF, Aurigemma GP, et al., ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelinesfor the Clinical Application of Echocardiography), J Am Soc Echocardiogr, 2003;16:1091–1110.
  • Visser CA, Kan G, David GK, Lie KI, Durrer D, Two dimensional echocardiography in the diagnosis of left ventricular thrombus. A prospective study of 67 patients with anatomic validation, Chest, 1983;83:228–32.
  • Ezekowitz MD, Wilson DA, Smith EO, et al., Comparison of Indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricularthrombi, N Engl J Med, 1982;306:1509–13.
  • Lamas GA, Vaughan DE, Pfeffer MA, Left ventricular thrombus formation after first anterior wall acute myocardial infarction, Am J Cardiol, 1988;62:31–5.
  • Greaves SC, Zhi G, Lee RT, et al., Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarction, Am J Cardiol, 1997;80:442–8.
  • Spirito P, Bellotti P, Chiarella F, et al., Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study, Circulation, 1985;72:774–80.
  • Toth C, Ujhelyi E, Fulop T, Istvan E, Clinical predictors of early left ventricular thrombus formation in acute myocardial infarction, Acta Cardiol, 2002;57:205–11.
  • Visser CA, Kan G, Meltzer RS, et al., Long-term follow-up of left ventricular thrombus after acute myocardial infarction. Atwo-dimensional echocardiographic study in 96 patients, Chest, 1984;86:532–6.
  • Pizzetti G, Belotti G, Margonato A, et al., Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size, Eur Heart J, 1996;17:421–8.
  • Grothues F, Smith GC, Moon JC, et al., Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography innormal subjects and in patients with heart failure or left ventricular hypertrophy, Am J Cardiol, 2002;90:29–34.
  • Thiele H, Nagel E, Paetsch I, et al., Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents, J Magn Reson Imaging, 2001;14:362–7.
  • Kim RJ, Fieno DS, Parrish TB, et al., Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function, Circulation, 1999;100: 1992–2002.
  • Fieno DS, Kim RJ, Chen EL, et al., Contrast-enhanced magnetic resonance imaging of myocardium at risk:distinction between reversible and irreversible injury throughout infarct healing, J Am Coll Cardiol, 2000;36:1985–91.
  • Jugdutt BI, Tang SB, Khan MI, Basualdo CA, Functionalimpact of remodeling during healing after non-Q wave versus Q wave anterior myocardial infarction in the dog, J Am Coll Cardiol, 1992;20:722–31.

    • Copyright® 2010 Business Briefings, Ltd. All rights reserved.
    Touch Cardiology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.